
Taofiq A. Solola
Examiner (ID: 15817)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1613, 1622, 1626, 1625 |
| Total Applications | 3197 |
| Issued Applications | 2337 |
| Pending Applications | 273 |
| Abandoned Applications | 640 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11677073
[patent_doc_number] => 09675580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Method of treatment for enhancing exercise performance'
[patent_app_type] => utility
[patent_app_number] => 15/058065
[patent_app_country] => US
[patent_app_date] => 2016-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 4265
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15058065
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/058065 | Method of treatment for enhancing exercise performance | Feb 29, 2016 | Issued |
Array
(
[id] => 13371761
[patent_doc_number] => 20180237421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/553540
[patent_app_country] => US
[patent_app_date] => 2016-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553540
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553540 | Substituted pyrazole compounds as serine protease inhibitors | Feb 28, 2016 | Issued |
Array
(
[id] => 11722270
[patent_doc_number] => 09695119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Methionine analogs and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 15/054761
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 28157
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054761 | Methionine analogs and methods of using same | Feb 25, 2016 | Issued |
Array
(
[id] => 13371833
[patent_doc_number] => 20180237457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => IMIDAZOPYRIDAZINE AND IMIDAZOTHIADIAZOLE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/549257
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 463
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549257
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549257 | Imidazopyridazine and imidazothiadiazole compounds | Feb 24, 2016 | Issued |
Array
(
[id] => 11343430
[patent_doc_number] => 09527825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Purification of taxanes'
[patent_app_type] => utility
[patent_app_number] => 15/053793
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 9425
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15053793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/053793 | Purification of taxanes | Feb 24, 2016 | Issued |
Array
(
[id] => 10820428
[patent_doc_number] => 20160166591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/046630
[patent_app_country] => US
[patent_app_date] => 2016-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27255
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15046630
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/046630 | Compositions and methods to treat cardiac diseases | Feb 17, 2016 | Issued |
Array
(
[id] => 14975393
[patent_doc_number] => 10441580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Iloperidone for the treatment of schizophrenia
[patent_app_type] => utility
[patent_app_number] => 15/549820
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4835
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549820
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549820 | Iloperidone for the treatment of schizophrenia | Feb 16, 2016 | Issued |
Array
(
[id] => 16305318
[patent_doc_number] => 10774096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => 4-substituted benzoxaborole compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/550693
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22771
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550693
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550693 | 4-substituted benzoxaborole compounds and uses thereof | Feb 11, 2016 | Issued |
Array
(
[id] => 10997366
[patent_doc_number] => 20160194312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'ACTIVATION OF TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND CRITICAL ROLE FOR TRPV4 IN ORGAN-SPECIFIC INFLAMMATION AND ITCH'
[patent_app_type] => utility
[patent_app_number] => 15/018595
[patent_app_country] => US
[patent_app_date] => 2016-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 17142
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15018595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/018595 | Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch | Feb 7, 2016 | Issued |
Array
(
[id] => 11722340
[patent_doc_number] => 09695187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein'
[patent_app_type] => utility
[patent_app_number] => 15/015161
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16124
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015161
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015161 | Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein | Feb 3, 2016 | Issued |
Array
(
[id] => 16885233
[patent_doc_number] => 20210171428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => METHOD FOR PRODUCING KETENE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/071204
[patent_app_country] => US
[patent_app_date] => 2016-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071204 | METHOD FOR PRODUCING KETENE DERIVATIVE | Jan 19, 2016 | Abandoned |
Array
(
[id] => 10784088
[patent_doc_number] => 20160130244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'OXIDATION PROCESS TO PRODUCE A PURIFIED CARBOXYLIC ACID PRODUCT VIA SOLVENT DISPLACEMENT AND POST OXIDATION'
[patent_app_type] => utility
[patent_app_number] => 14/995901
[patent_app_country] => US
[patent_app_date] => 2016-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12517
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14995901
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/995901 | Oxidation process to produce a purified carboxylic acid product via solvent displacement and post oxidation | Jan 13, 2016 | Issued |
Array
(
[id] => 13702519
[patent_doc_number] => 20170362214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => DERIVATIVES OF 3-HETEROARYLISOXAZOL-5-CARBOXYLIC AMIDE USEFUL FOR THE TREATMENT OF INTER ALIA CYSTIC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 15/539405
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539405
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539405 | Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis | Dec 22, 2015 | Issued |
Array
(
[id] => 11283740
[patent_doc_number] => 09499583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Antibacterial antisense oligonucleotide and method'
[patent_app_type] => utility
[patent_app_number] => 14/977451
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 43
[patent_no_of_words] => 38681
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14977451
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/977451 | Antibacterial antisense oligonucleotide and method | Dec 20, 2015 | Issued |
Array
(
[id] => 16305317
[patent_doc_number] => 10774095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Method of synthesizing metal-ascorbic acid crystals
[patent_app_type] => utility
[patent_app_number] => 14/963897
[patent_app_country] => US
[patent_app_date] => 2015-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 1903
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14963897
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/963897 | Method of synthesizing metal-ascorbic acid crystals | Dec 8, 2015 | Issued |
Array
(
[id] => 10997352
[patent_doc_number] => 20160194298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'PROCESS FOR PRODUCTION OF HEXANETRIOL FROM 5-HYDROXYMETHYLFURFURAL'
[patent_app_type] => utility
[patent_app_number] => 14/957551
[patent_app_country] => US
[patent_app_date] => 2015-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 42892
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14957551
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/957551 | Process for production of hexanetriol from 5-hydroxymethylfurfural | Dec 1, 2015 | Issued |
Array
(
[id] => 12346602
[patent_doc_number] => 09951037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Process for the preparation of 4-phenyldibenzothiophene
[patent_app_type] => utility
[patent_app_number] => 15/525492
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5393
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525492 | Process for the preparation of 4-phenyldibenzothiophene | Nov 30, 2015 | Issued |
Array
(
[id] => 15816457
[patent_doc_number] => 10633394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Heterocyclic derivatives and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/528571
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21411
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 355
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15528571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/528571 | Heterocyclic derivatives and use thereof | Nov 29, 2015 | Issued |
Array
(
[id] => 12999867
[patent_doc_number] => 10023591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Heterocyclic derivatives and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/526415
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29067
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 447
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526415
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/526415 | Heterocyclic derivatives and use thereof | Nov 29, 2015 | Issued |
Array
(
[id] => 10765493
[patent_doc_number] => 20160111649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'SPIRALLY CONFIGURED CIS-STILBENE/FLUORENE HYBRID MATERIALS AS HOLE-BLOCKING TYPE ELECTRON-TRANSPORTERS FOR OLED'
[patent_app_type] => utility
[patent_app_number] => 14/954516
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4126
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14954516
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/954516 | Spirally configured cis-stilbene/fluorene hybrid materials as hole-blocking type electron-transporters for OLED | Nov 29, 2015 | Issued |